Skip to main content

ADVERTISEMENT

Jessica Garlewicz, Digital Managing Editor

alopecia areata
News
12/12/2023
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate...
12/12/2023
The Dermatologist
NPF Endorsed Features
12/05/2023
Jessica Garlewicz, Digital Managing Editor
Proper evaluation and history collection are essential for accurate diagnosis and timely treatment.
Proper evaluation and history collection are essential for accurate diagnosis and timely treatment.
Proper evaluation and history...
12/05/2023
The Dermatologist
Dr Benjamin Ungar
Conference Coverage
12/01/2023
Jessica Garlewicz, Digital Managing Editor
Prior to his session, Dr Benjamin Ungar discussed the epidemiology of alopecia areata in the context of a broader symposium covering various aspects of the disease.
Prior to his session, Dr Benjamin Ungar discussed the epidemiology of alopecia areata in the context of a broader symposium covering various aspects of the disease.
Prior to his session, Dr...
12/01/2023
The Dermatologist
Dr Peter Lio
Conference Coverage
12/01/2023
Jessica Garlewicz, Digital Managing Editor
During his session, Peter Lio, MD, discussed holistic approaches to treating atopic dermatitis and alopecia areata.
During his session, Peter Lio, MD, discussed holistic approaches to treating atopic dermatitis and alopecia areata.
During his session, Peter Lio,...
12/01/2023
The Dermatologist
alopecia areata
News
11/30/2023
Jessica Garlewicz, Digital Managing Editor
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results...
11/30/2023
The Dermatologist
alopecia areata
News
11/20/2023
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the...
11/20/2023
The Dermatologist
alopecia areata
News
11/17/2023
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the...
11/17/2023
The Dermatologist
alopecia areata
News
11/16/2023
Jessica Garlewicz, Digital Managing Editor
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for...
11/16/2023
The Dermatologist
Ilka Arun Netravali, MD, PhD, FAAD
Quiz
11/07/2023
Jessica Garlewicz, Digital Managing Editor
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview...
11/07/2023
The Dermatologist
FDA Alerts
11/01/2023
Jessica Garlewicz, Digital Managing Editor
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug...
11/01/2023
The Dermatologist